Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11, ... Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11, leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.13 | -8.66666666667 | 1.5 | 1.54 | 1.3101 | 118388 | 1.46385121 | CS |
4 | -0.11 | -7.43243243243 | 1.48 | 2.03 | 1.3101 | 329446 | 1.77069116 | CS |
12 | -0.52 | -27.5132275132 | 1.89 | 2.22 | 1.14 | 580950 | 1.59974058 | CS |
26 | -5.755 | -80.7719298246 | 7.125 | 7.25 | 1.14 | 2218270 | 2.66035625 | CS |
52 | -9.4175 | -87.3001158749 | 10.7875 | 17.1125 | 1.14 | 1273972 | 3.49152957 | CS |
156 | -18.63 | -93.15 | 20 | 31.5 | 1.14 | 661980 | 6.35471711 | CS |
260 | -18.63 | -93.15 | 20 | 31.5 | 1.14 | 661980 | 6.35471711 | CS |
Symbole | Prix | Vol. |
---|---|---|
SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 25,06 (-23,25%) | 196,04M |
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF | US$ 3,78 (33,81%) | 130,6M |
SOXSDirexion Daily Semiconductor Bear 3X Shares New | US$ 22,22 (22,83%) | 113,36M |
SPXSDirexion Daily S&P 500 Bear 3X Shares New | US$ 5,89 (4,25%) | 103,9M |
MJUSAmplify US Alternative Harvest ETF | US$ 0,7584 (-2,77%) | 76,69M |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales